Grant Williams, M.D.

Regulatory Strategy

Grant Williams has 16 years experience in clinical trial design and drug regulation at the FDA. At the FDA, he was a reviewer for 15 NDAs and a team leader for 20 more - including Gleevec. More recently, he has worked at Novartis and GSK chairing the oncology protocol committees. He has 3 years experience in clinical design and drug development at those companies. He also has 2 1/2 years consulting experience for a broad range of oncology drug companies.